Developer docs
API playgroundTry for free, no card

Search company profiles

Entourage Effect Capital

Full company profile

uuid00093m6

Namestring
Entourage Effect Capital
Legal namestring
Entourage Effect Capital, LLC
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Entourage Effect Capital (EEC) is a private investment firm founded in 2014 by Matthew Hawkins and headquartered in Dallas, Texas, dedicated exclusively to investing in the cannabis industry. The firm manages three distinct investment funds aligned to successive industry cycles: Fund I targets early innovators with forward-thinking business models, Fund II focuses on emerging growth companies demonstrating manufacturing efficiency and product innovation, and Fund III invests in companies positioned to scale ahead of federal legalization. Across these funds, EEC has assembled a portfolio of more than 70 companies spanning plant-touching operators, ancillary and services platforms, production and consumer brands, and science and technology applications, including category-defining names such as Curaleaf, Acreage Holdings, Green Thumb Industries, Canopy Growth, TerrAscend, Cookies, and Dama Financial.

The firm invests both directly and as a co-investment partner via the Arcview Ventures Seed Fund, which has given EEC access to seed-stage opportunities including Abstrax, Hoodie Analytics, The House of Cannabis, and BioLumic. The core team comprises nine professionals — Co-founders/Managing Partners Matthew Hawkins and Andy Sturner, Co-founder Dov Szapiro, Managing Directors Tiffany Liff, Joe Blasetti, and Roman Stahl, Vice President Nick Bellamy, and Operations Manager Georgia Underwood — supplemented by an outsourced CFO (John Heyde via Baker Tilly) and four external advisors drawn from major cannabis and finance institutions (Jason Wild of JW Asset Management, Kevin Albert of Pantheon, Brian Rosen of BevStrat/InvestBev, and Avi Weintraub).

EEC generates returns through fund management, taking equity stakes in portfolio companies and realizing liquidity through exits such as the 2017 Form Factory sale to Acreage Holdings for $160mm at a 14.4x multiple on cost, and additional exits via Curaleaf, StateHouse Holdings, TILT Holdings, Akerna, and CURE Pharmaceuticals. Investment opportunities are distributed to accredited investors through a restricted Carta portal rather than mass marketing, with deal flow sourced through principal networks and portfolio-company referrals. The firm does not publicly disclose AUM, management fees, or fund sizes.

Short descriptiontext

Entourage Effect Capital is a Dallas-based private investment firm founded in 2014 that manages three cannabis-focused funds spanning early-stage, emerging growth, and pre-legalization positioning, with over 70 portfolio companies across plant-touching, ancillary, production, and science/technology sectors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis private equity, cannabis venture capital, cannabis investment funds, plant-touching investments, cannabis ancillary investing
Industry1 code
PRIMARYFSANAAAG
Impact / ESG Venture Capital
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • Other Investment Pools and Funds5259
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Private Equity / Venture Capital (Cannabis)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management / Investment Returns
TypeManaged Services
Description

EEC generates returns through equity investments in cannabis companies across multiple funds (Fund I, II, III). The fund takes ownership stakes in portfolio companies and realizes returns through exits and distributions. Notable exits include Form Factory sale to Acreage Holdings for $160mm (14.4x MoC).

entourageeffect.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Entourage Effect Capital (EEC) is a cannabis-focused private investment firm that manages three distinct investment funds (Fund I, II, and III) deploying capital into cannabis-related companies. The firm takes equity stakes across plant-touching operators, ancillary and services providers, production and brand companies, and cannabis science and technology ventures, and supports portfolio companies with M&A advisory, business development, and operational guidance. EEC also makes co-investments via the Arcview Ventures Seed Fund.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 14.4x Money on Cost on Form Factory exit to Acreage Holdings for $160mm
+1 more record
Product overview1 text field

Entourage Effect Capital is a cannabis-focused private equity investment firm operating three distinct investment funds targeting different stages of the cannabis industry lifecycle. Fund I targets early innovators with forward-thinking business models; Fund II focuses on emerging growth companies demonstrating manufacturing efficiency and product innovation; Fund III invests in companies positioned to scale ahead of federal legalization. The firm also provides portfolio management, investor relations services, and operational support to its portfolio companies.

Product and service3 records
1Fund III
CategoryInvestment Fund
Description

A private equity fund investing in cannabis companies positioned to scale ahead of federal legalization, with sector focus on plant-touching operators, ancillary and services providers, production and brand companies, and science and technology ventures.

2Fund II
CategoryInvestment Fund
Description

A private equity fund focused on emerging growth cannabis companies demonstrating manufacturing efficiency and product innovation across plant-touching, ancillary & services, production & brands, and science & technology sectors.

3Fund I
CategoryInvestment Fund
Description

The original EEC fund focused on early cannabis innovators leveraging forward-thinking business models in the legal cannabis industry across plant-touching and ancillary & services sectors.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cannabis-focused venture capital firm investing across the cannabis value chain from plant-touching to ancillary. Highly comparable to EEC given its sector specialization and multi-fund structure.

TypeDirect peer
Description

Cannabis-focused private equity fund with multiple vintages investing in plant-touching operators and ancillary services. Directly comparable multi-fund cannabis PE strategy to EEC.

TypeDirect peer
Description

Early-mover cannabis-focused hedge fund and private investment firm with deep MSO exposure. Comparable to EEC as a sector-specialist deploying capital across cannabis stages.

TypeDirect peer
Description

Cannabis-focused venture capital firm making seed and early-stage investments in cannabis-adjacent technology, brands, and operators. Direct peer in the cannabis VC sub-segment.

5CanopyBoulder
TypeDirect peer
Description

Cannabis-specific accelerator and seed fund backing ancillary and plant-touching startups. Comparable early-stage, sector-specialized model to EEC's Arcview co-investments.

TypeDirect peer
Description

Cannabis-focused investment network and fund-of-funds platform; an EEC portfolio company and co-investment partner. Highly comparable as a cannabis-specialist capital allocator.

TypeDirect peer
Description

$1.9B AUM cannabis-heavy fund manager led by Jason Wild (EEC advisor/LPAC). Closely comparable in cannabis allocation strategy and public/private blending.

TypeDirect peer
Description

Cannabis-focused hedge fund and private investment firm with long-standing MSO exposure. Comparable to EEC as a sector-specialist allocator targeting cannabis growth stages.

TypeDirect peer
Description

Cannabis-focused alternative investment manager deploying across the cannabis value chain. Comparable as a multi-fund, sector-specialist allocator with similar vintage strategy.

TypeEmerging player
Description

Cannabis operator and brand platform backed by celebrity and institutional capital; representative of MSO/operator companies that overlap with EEC's portfolio direction (production/brands segment).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment11 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Entourage Effect Capital

Private Equity / Venture Capital (Cannabis)entourageeffect.com

Entourage Effect Capital is a Dallas-based private investment firm founded in 2014 that manages three cannabis-focused funds spanning early-stage, emerging growth, and pre-legalization positioning, with over 70 portfolio companies across plant-touching, ancillary, production, and science/technology sectors.

What Entourage Effect Capital does

Entourage Effect Capital (EEC) is a private investment firm founded in 2014 by Matthew Hawkins and headquartered in Dallas, Texas, dedicated exclusively to investing in the cannabis industry. The firm manages three distinct investment funds aligned to successive industry cycles: Fund I targets early innovators with forward-thinking business models, Fund II focuses on emerging growth companies demonstrating manufacturing efficiency and product innovation, and Fund III invests in companies positioned to scale ahead of federal legalization. Across these funds, EEC has assembled a portfolio of more than 70 companies spanning plant-touching operators, ancillary and services platforms, production and consumer brands, and science and technology applications, including category-defining names such as Curaleaf, Acreage Holdings, Green Thumb Industries, Canopy Growth, TerrAscend, Cookies, and Dama Financial.

The firm invests both directly and as a co-investment partner via the Arcview Ventures Seed Fund, which has given EEC access to seed-stage opportunities including Abstrax, Hoodie Analytics, The House of Cannabis, and BioLumic. The core team comprises nine professionals — Co-founders/Managing Partners Matthew Hawkins and Andy Sturner, Co-founder Dov Szapiro, Managing Directors Tiffany Liff, Joe Blasetti, and Roman Stahl, Vice President Nick Bellamy, and Operations Manager Georgia Underwood — supplemented by an outsourced CFO (John Heyde via Baker Tilly) and four external advisors drawn from major cannabis and finance institutions (Jason Wild of JW Asset Management, Kevin Albert of Pantheon, Brian Rosen of BevStrat/InvestBev, and Avi Weintraub).

EEC generates returns through fund management, taking equity stakes in portfolio companies and realizing liquidity through exits such as the 2017 Form Factory sale to Acreage Holdings for $160mm at a 14.4x multiple on cost, and additional exits via Curaleaf, StateHouse Holdings, TILT Holdings, Akerna, and CURE Pharmaceuticals. Investment opportunities are distributed to accredited investors through a restricted Carta portal rather than mass marketing, with deal flow sourced through principal networks and portfolio-company referrals. The firm does not publicly disclose AUM, management fees, or fund sizes.

Entourage Effect Capital firmographics

Firmographics
Name
Entourage Effect Capital
Legal name
Entourage Effect Capital, LLC
Website
https://entourageeffect.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Entourage Effect Capital is a Dallas-based private investment firm founded in 2014 that manages three cannabis-focused funds spanning early-stage, emerging growth, and pre-legalization positioning, with over 70 portfolio companies across plant-touching, ancillary, production, and science/technology sectors.
Ownership category
akta.pro rank

Entourage Effect Capital industry classification

Industry
Product category
Private Equity / Venture Capital (Cannabis)
NAICS
Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAG
Impact / ESG Venture Capital

Keywords

  • Cannabis private equity
  • Cannabis venture capital
  • Cannabis investment funds
  • Plant-touching investments
  • Cannabis ancillary investing

Where Entourage Effect Capital is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Entourage Effect Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Fund Management / Investment Returns: EEC generates returns through equity investments in cannabis companies across multiple funds (Fund I, II, III). The fund takes ownership stakes in portfolio companies and realizes returns through exits and distributions. Notable exits include Form Factory sale to Acreage Holdings for $160mm (14.4x MoC).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Entourage Effect Capital product offering

Product offering

Core offering

Entourage Effect Capital (EEC) is a cannabis-focused private investment firm that manages three distinct investment funds (Fund I, II, and III) deploying capital into cannabis-related companies. The firm takes equity stakes across plant-touching operators, ancillary and services providers, production and brand companies, and cannabis science and technology ventures, and supports portfolio companies with M&A advisory, business development, and operational guidance. EEC also makes co-investments via the Arcview Ventures Seed Fund.

Product overview

Entourage Effect Capital is a cannabis-focused private equity investment firm operating three distinct investment funds targeting different stages of the cannabis industry lifecycle. Fund I targets early innovators with forward-thinking business models; Fund II focuses on emerging growth companies demonstrating manufacturing efficiency and product innovation; Fund III invests in companies positioned to scale ahead of federal legalization. The firm also provides portfolio management, investor relations services, and operational support to its portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Fund III A private equity fund investing in cannabis companies positioned to scale ahead of federal legalization, with sector focus on plant-touching operators, ancillary and services providers, production and brand companies, and science and technology ventures.
  • Fund II A private equity fund focused on emerging growth cannabis companies demonstrating manufacturing efficiency and product innovation across plant-touching, ancillary & services, production & brands, and science & technology sectors.
  • Fund I The original EEC fund focused on early cannabis innovators leveraging forward-thinking business models in the legal cannabis industry across plant-touching and ancillary & services sectors.

Quantifiable outcome

  • 14.4x Money on Cost on Form Factory exit to Acreage Holdings for $160mm
  • +1 more outcomes

Companies that use Entourage Effect Capital

Customer profile

Segments4 records

Ideal customer profiles5 records

Entourage Effect Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Entourage Effect Capital partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Entourage Effect Capital competitors and assessment

Company assessment

Direct peers

  • Casa Verde Capital: Cannabis-focused venture capital firm investing across the cannabis value chain from plant-touching to ancillary. Highly comparable to EEC given its sector specialization and multi-fund structure.
  • Merida Capital Partners: Cannabis-focused private equity fund with multiple vintages investing in plant-touching operators and ancillary services. Directly comparable multi-fund cannabis PE strategy to EEC.
  • Poseidon Asset Management: Early-mover cannabis-focused hedge fund and private investment firm with deep MSO exposure. Comparable to EEC as a sector-specialist deploying capital across cannabis stages.
  • Phyto Partners: Cannabis-focused venture capital firm making seed and early-stage investments in cannabis-adjacent technology, brands, and operators. Direct peer in the cannabis VC sub-segment.
  • CanopyBoulder: Cannabis-specific accelerator and seed fund backing ancillary and plant-touching startups. Comparable early-stage, sector-specialized model to EEC's Arcview co-investments.
  • Arcview Group: Cannabis-focused investment network and fund-of-funds platform; an EEC portfolio company and co-investment partner. Highly comparable as a cannabis-specialist capital allocator.
  • JW Asset Management: $1.9B AUM cannabis-heavy fund manager led by Jason Wild (EEC advisor/LPAC). Closely comparable in cannabis allocation strategy and public/private blending.
  • Navy Capital: Cannabis-focused hedge fund and private investment firm with long-standing MSO exposure. Comparable to EEC as a sector-specialist allocator targeting cannabis growth stages.
  • Salveo Capital: Cannabis-focused alternative investment manager deploying across the cannabis value chain. Comparable as a multi-fund, sector-specialist allocator with similar vintage strategy.

Emerging players

  • TPCO Holding Corp (The Parent Company): Cannabis operator and brand platform backed by celebrity and institutional capital; representative of MSO/operator companies that overlap with EEC's portfolio direction (production/brands segment).

Market position

Strengths4 records

Weaknesses2 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Entourage Effect Capital social profiles

Digital presence

Entourage Effect Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Entourage Effect Capital leadership team

Management profile

Number of profiles

Profiles13 records

Entourage Effect Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Entourage Effect Capital M&A and investment

M&A and investment

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Entourage Effect Capital

What does Entourage Effect Capital do?

Entourage Effect Capital (EEC) is a cannabis-focused private investment firm that manages three distinct investment funds (Fund I, II, and III) deploying capital into cannabis-related companies. The firm takes equity stakes across plant-touching operators, ancillary and services providers, production and brand companies, and cannabis science and technology ventures, and supports portfolio companies with M&A advisory, business development, and operational guidance. EEC also makes co-investments via the Arcview Ventures Seed Fund.

Is Entourage Effect Capital a public or private company?

Entourage Effect Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Entourage Effect Capital founded?

Entourage Effect Capital was founded in 2014. It employs 1 to 10 people.

Where is Entourage Effect Capital based?

Entourage Effect Capital is headquartered in Dallas, United States, in the North America region.

How does Entourage Effect Capital make money?

One revenue line is on record: fund Management / Investment Returns.

Who are Entourage Effect Capital's main competitors?

Direct peers on record are Casa Verde Capital, Merida Capital Partners, Poseidon Asset Management, Phyto Partners, CanopyBoulder, Arcview Group, JW Asset Management, Navy Capital and Salveo Capital. TPCO Holding Corp (The Parent Company) is listed as an emerging player.

Does Entourage Effect Capital have an API?

No public API is recorded for Entourage Effect Capital.

What industry is Entourage Effect Capital in?

Entourage Effect Capital's product category is Private Equity / Venture Capital (Cannabis). Its primary akta.pro industry code is FSANAAAG, Impact / ESG Venture Capital. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Visible.vc12+ Cannabis Venture Capital Investors to Know in 2025The article provides a comprehensive overview of the 2025 cannabis venture capital landscape, highlighting key investment trends in technology, health and wellness, and sustainability. It profiles over a dozen active venture capital firms, such as KEY Investment Partners and Entourage Effect Capital, that are funding startups across the U.S. and globally. The piece also details emerging market growth projections, regulatory shifts, and alternative funding strategies like crowdfunding and grants.https://www.wflx.comCannabis industry leaders hot for pot, but not high on investing yetCannabis industry leaders discussed Florida's November recreational marijuana ballot at the Benzinga Cannabis Capital Conference, with many eyeing the state's large population and tourist appeal. Investors like Matt Hawkins of Entourage Effect Capital have not yet invested in Florida, citing regulatory uncertainty and waiting for legalization. The DEA is expected to reschedule marijuana's classification this spring.TechCrunchCan Europe’s cannabis market avoid the US’ mistakes? Investors chime inGermany scaled back its plans for legalizing recreational cannabis, a decision that has caused investors like Entourage Effect Capital to become more hesitant about deploying capital in the European market due to concerns over limited total addressable market. Despite this regulatory slowdown, the medical and pharmaceutical sectors are seeing growth driven by increased clinical data and acceptance, leading to expectations of industry consolidation as companies adjust to a tougher macroeconomic environment. Investors emphasize learning from US mistakes to avoid blurring lines between medical and recreational markets while focusing on cash flow preservation.TechCrunchDespite regulatory hurdles, these 4 US cannabis investors are planting seeds for tomorrowSpecialized investment firms including Poseidon, Entourage Effect Capital, and Casa Verde Capital are actively deploying capital into the U.S. cannabis sector, focusing on ancillary businesses and infrastructure to preempt institutional entry despite federal regulatory hurdles. Investors highlight that while state-level legalization continues to expand market size, the lack of traditional banking access remains a primary impediment to industry growth and valuation stability.TechCrunch4 investors discuss the US cannabis market’s prospects in Q3 2022Four cannabis investors—Emily Paxhia of Poseidon, Yoni Meyer of Casa Verde Capital, Matt Hawkins of Entourage Effect Capital, and Jacqueline Bennett of Highlands Venture Partners—discussed their outlook for the US cannabis market in Q3 2022, expressing continued optimism despite federal illegality and market headwinds. The investors see opportunities in both ancillary (back-end) and plant-touching companies, noting valuations at rock-bottom levels are attracting new limited partners to their funds. While generalist investors have pulled back due to regulatory hurdles, specialist cannabis investors expect traditional capital to eventually recognize the sector's long-term potential.Las Vegas Review-JournalInvesting in cannabis: What to know before you beginMatt Hawkins, partner at Entourage Effect Capital, has committed $200 million to 68 legal cannabis investments. He advises public investors to use ETFs and notes that only 16 states have full legalization, with Illinois still working out details. He expects the U.S. to become the largest marijuana market once legalization is nationwide.BenzingaLow-Cost Pot Stocks To Consider, According To Entourage Effect Capital's Codie Sanchez - CRESCO LABS INCEntourage Effect Capital Managing Director Codie Sanchez outlined investment parameters for the cannabis sector, recommending established operators like Green Thumb Industries, Curaleaf Holdings, Terrascend Corp., Harborside Inc., and Cresco Labs while cautioning against penny stocks and OTC equities. She emphasized the importance of vetting management teams and examining companies' historical track records before investing. Sanchez advised investors with limited capital to prioritize more established names despite their higher share prices.MgmagazineContrarian Investor Codie Sanchez Is a New Breed of Cannabis DisruptorCodie Sanchez, managing director at Entourage Effect Capital, has invested over $100 million across more than 40 cannabis companies. She sees the industry as a generational wealth-creation opportunity and is exploring investments in lab testing and Latin American markets.PR NewswireCresco Capital Partners Becomes Entourage Effect Capital; Launches Largest Cannabis Venture Fund YetCresco Capital Partners announced the launch of Fund III with an initial target of $150 million, representing its largest fund to date, and simultaneously rebranded to Entourage Effect Capital (EEC). When fully subscribed, the new fund will bring total assets under management to approximately $250 million, up from the firm's current $100 million in AUM since its founding in 2014. The diversified fund will target growth stage companies across the cannabis value chain including science, licensing, retail, consumer goods, and ancillary services, with plans to invest in 10–20 companies over a five-year investment period.